Association of peripheral arterial disease with short-term case fatality and long-term mortality in patients with incident acute myocardial infarction. Results from the MONICA/KORA Myocardial Infarction Registry

[1]  A. Peters,et al.  Presenting symptoms, pre-hospital delay time and 28-day case fatality in patients with peripheral arterial disease and acute myocardial infarction from the MONICA/KORA Myocardial Infarction Registry , 2017, European journal of preventive cardiology.

[2]  E. Freisinger,et al.  Peripheral artery disease is associated with high in-hospital mortality particularly in males with acute myocardial infarction in a nationwide real-world setting. , 2016, VASA. Zeitschrift fur Gefasskrankheiten.

[3]  K. Mahaffey,et al.  Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial , 2015, European journal of preventive cardiology.

[4]  Deepak L. Bhatt,et al.  Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study , 2015, European journal of preventive cardiology.

[5]  M Hassan Murad,et al.  Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. , 2015, Journal of vascular surgery.

[6]  S. Solomon,et al.  Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT. , 2013, International journal of cardiology.

[7]  I. Barbash,et al.  Comparison of adverse outcomes after contemporary percutaneous coronary intervention in women versus men with acute coronary syndrome. , 2013, The American journal of cardiology.

[8]  L. Mosca,et al.  Fifteen-Year Trends in Awareness of Heart Disease in Women: Results of a 2012 American Heart Association National Survey , 2013, Circulation.

[9]  C. D. Owens,et al.  Medical management of peripheral arterial disease: bridging the "gap"? , 2012, Circulation.

[10]  Deepak L. Bhatt,et al.  Polyvascular Disease and Long-Term Cardiovascular Outcomes in Older Patients With Non–ST-Segment–Elevation Myocardial Infarction , 2012, Circulation. Cardiovascular quality and outcomes.

[11]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[12]  A. Gomes,et al.  A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. , 2012, Circulation.

[13]  M. Zubaid,et al.  Peripheral Arterial Disease in Patients Presenting with Acute Coronary Syndrome in Six Middle Eastern Countries , 2011, International journal of vascular medicine.

[14]  M. Flather,et al.  High Risk of Peripheral Arterial Disease in the United Kingdom: 2-Year Results of a Prospective Registry , 2011, Angiology.

[15]  J. Mehlsen,et al.  High prevalence of peripheral arterial disease in patients with previous cerebrovascular or coronary event , 2010, Blood pressure.

[16]  A. Jeremias,et al.  Effect of peripheral arterial disease on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction. , 2010, The American journal of cardiology.

[17]  J. Collet,et al.  Impact of polyvascular disease on baseline characteristics, management and mortality in acute myocardial infarction. The Alliance project. , 2010, Archives of cardiovascular diseases.

[18]  G. Pera,et al.  The Peripheral Arterial disease study (PERART/ARTPER): prevalence and risk factors in the general population , 2010, BMC public health.

[19]  E. Jude,et al.  Peripheral arterial disease in diabetes—a review , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[20]  Deepak L. Bhatt,et al.  Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. , 2009, European heart journal.

[21]  C. Meisinger,et al.  20‐year trends in clinical characteristics, therapy and short‐term prognosis in acute myocardial infarction according to presenting electrocardiogram: the MONICA / KORA AMI Registry (1985–2004) , 2008, Journal of internal medicine.

[22]  M. Criqui,et al.  Gaps in Public Knowledge of Peripheral Arterial Disease: The First National PAD Public Awareness Survey , 2007, Circulation.

[23]  Á. Avezum,et al.  Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events). , 2007, The American journal of cardiology.

[24]  C. Meisinger,et al.  Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusion era. , 2006, International journal of cardiology.

[25]  Deepak L. Bhatt,et al.  The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. , 2006, Journal of the American College of Cardiology.

[26]  Rodney A. White,et al.  ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Intervent , 2006, Journal of vascular and interventional radiology : JVIR.

[27]  Á. Avezum,et al.  Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). , 2006, American heart journal.

[28]  K. Harjai,et al.  Usefulness of the presence of peripheral vascular disease in predicting mortality in acute myocardial infarction patients treated with primary angioplasty (from the Primary Angioplasty in Myocardial Infarction Database). , 2005, The American journal of cardiology.

[29]  C. Cannon,et al.  Peripheral arterial disease, acute coronary syndromes, and early invasive management: The TACTICS TIMI 18 trial , 2005, Clinical cardiology.

[30]  B. Lewis,et al.  Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 stu , 2003, American heart journal.

[31]  Ian Graham,et al.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). , 2011, Atherosclerosis.

[32]  J. Gore,et al.  Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting. , 2007, American heart journal.

[33]  Kora Myocardial.  Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusion era , 2007 .

[34]  J. Allenberg,et al.  High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. , 2004, Atherosclerosis.

[35]  M. Criqui,et al.  Peripheral arterial disease detection, awareness, and treatment in primary care. , 2001, JAMA.